Skip to main content
Clinical Trials/NCT00000254
NCT00000254
Completed
Phase 2

Isoflurane at Subanesthetic Concentrations

University of Chicago1 site in 1 country10 target enrollmentJanuary 1995

Overview

Phase
Phase 2
Intervention
40% Nitrous oxide
Conditions
Opioid-Related Disorders
Sponsor
University of Chicago
Enrollment
10
Locations
1
Primary Endpoint
Pain response
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To test the hypothesis that isoflurane at subanesthetic concentrations does not reduce cold-water immersion pain in healthy volunteers.

Registry
clinicaltrials.gov
Start Date
January 1995
End Date
September 1995
Last Updated
10 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

0% isoflurane

Intervention: 40% Nitrous oxide

0% isoflurane

Intervention: Sham comparator

0.2% isoflurane

Intervention: 40% Nitrous oxide

0.2% isoflurane

Intervention: 0.2% isoflurane

0.4% isoflurane

Intervention: 40% Nitrous oxide

0.4% isoflurane

Intervention: 0.4% isoflurane

0.6% isoflurane

Intervention: 40% Nitrous oxide

0.6% isoflurane

Intervention: 0.6% isoflurane

Outcomes

Primary Outcomes

Pain response

Time Frame: Post inhalation

Effects of inhaled isoflurane on pain from immersion of subject's arm in ice cold water. Nitrous oxide (40%) was used as a positive control to confirm sensitivity of the pain assay.

Study Sites (1)

Loading locations...

Similar Trials